Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene

British Journal of Dermatology

Volumn 167, Issue 4, 2012, Pages 929-936

  Schumann, H ^a,b   Roth, W ^c   Has, C ^a   Volz, A ^d   Erfurt Berge, C ^e   Magin, T M ^c   Bruckner Tuderman, L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Catholic University of Applied Sciences   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CATENIN; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; DESMOCOLLIN; DESMOCOLLIN 2; ETRETIN; KI 67 ANTIGEN; PROTEIN P120; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CANCER INVASION; CANCER RISK; CARBON DIOXIDE LASER; CASE REPORT; CELL JUNCTION; CELL VIABILITY; DESMOSOME; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KERATODERMA; LOW LEVEL LASER THERAPY; MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; VERRUCOUS CARCINOMA;

ADULT; CADHERINS; CARCINOMA, VERRUCOUS; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; EPIDERMOLYSIS BULLOSA SIMPLEX; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATIN-5; KERATINOCYTES; KERATINS; KI-67 ANTIGEN; MUTATION; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867056696     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11075.x     Document Type: Article

References (28)

1. Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 931-50.
2. McGrath JA, Bolling MC, Jonkman MF,. Lethal acantholytic epidermolysis bullosa. Dermatol Clin 2010; 28: 131-5.
3. Groves RW, Liu L, Dopping-Hepenstal PJ, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 2010; 130: 1551-7.
4. Arin MJ, Grimberg G, Schumann H, et al. Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. Br J Dermatol 2010; 162: 1365-9.
5. Müller FB, Anton-Lamprecht I, Küster W, et al. A premature stop codon mutation in the 2B helix termination peptide of keratin 5 in a German epidermolysis bullosa simplex Dowling Meara case. J Invest Dermatol 1999; 112: 988-90.
6. Kang TW, Lee JS, Kim SE, et al. Novel and recurrent mutations in keratin 5 and 14 in korean patients with epidermolysis bullosa simplex. J Dermatol Sci 2010; 57: 90-4.
7. Rugg EL, Horn HM, Smith FJ, et al. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol 2007; 127: 574-80.
8. Lu H, Chen J, Planko L, et al. Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol 2007; 127: 2781-9.
9. Yoneda K, Furukawa T, Zheng YJ, et al. An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J Biol Chem 2004; 279: 7296-303.
10. Roth W, Reuter U, Wohlenberg C, et al. Cytokines as genetic modifiers in K5(-/-) mice and in human epidermolysis bullosa simplex. Hum Mutat 2009; 30: 832-41.
11. Baek JO, Lee HY, Oh SW, et al. A novel homozygous keratin 14 mutation in a patient with autosomal recessive epidermolysis bullosa simplex and squamous cell carcinoma of the tongue. Br J Dermatol 2010; 162: 880-2.
12. Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009; 60: 203-11.
13. Kern JS, Kohlhase J, Bruckner-Tuderman L, et al. Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 2006; 126: 1006-12.
14. Kontny U, Boppana S, Jung A, et al. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation. Haematologica 2005; 90: e77-80.
15. Bolling MC, Memmink HH, Jansen GHL, et al. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol 2011; 164: 637-44.
16. Jerábková B, Marek J, Bucková H, et al. Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure. Br J Dermatol 2010; 162: 1004-13.
17. Pfendner EG, Sadowski SG, Uitto J,. Epidermolysis bullosa simplex: recurrent and de novo mutations in the KRT5 and KRT14 genes, phenotype/genotype correlations, and implications for genetic counseling and prenatal diagnosis. J Invest Dermatol 2005; 125: 239-43.
18. Müller FB, Küster W, Wodecki K, et al. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly. Hum Mutat 2006; 27: 719-20.
19. Yasukawa K, Sawamura D, Goto M, et al. Epidermolysis bullosa simplex in Japanese and Korean patients: genetic studies in 19 cases. Br J Dermatol 2006; 155: 313-17.
20. Liovic M, D'Alessandro M, Tomic-Canic M, et al. Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratins. Exp Cell Res 2009; 315: 2995-3003.
21. Perez-Moreno M, Davis MA, Wong E, et al. p120-catenin mediates inflammatory responses in the skin. Cell 2006; 124: 631-44.
22. Davis MA, Ireton RC, Reynolds AB,. A core function for p120-catenin in cadherin turnover. J Cell Biol 2003; 163: 525-34.
23. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-93.
24. Nair KS, Naidoo R, Chetty R,. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 2005; 58: 343-51.
25. Dusek RL, Attardi LD,. Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer 2011; 11: 317-23.
26. Ke H, Parron VI, Reece J, et al. BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization. Cell Res 2010; 20: 458-69.
27. Assmann G, Sotlar K,. HPV-associated squamous cell carcinogenesis. Pathologe 2011; 32: 391-8.
28. Stacey SN, Sulem P, Masson G, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009; 41: 909-14.